SCHEMBL28061682

SCHEMBL28061682

O=C(Cl)c1cc(Cl)cc(C(F)(F)F)c1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TMPRSS4 Q9NRS4 9/20 0.36
P2RX1 P51575 3/20 0.35
KDR P35968 2/20 0.35
MEN1 O00255 1/20 0.35
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35
FLT3 P36888 1/20 0.35
KMT2A Q03164 1/20 0.35
MYLK Q15746 1/20 0.35
P2RX4 Q99571 1/20 0.35
P2RX7 Q99572 1/20 0.35
MAP4K5 Q9Y4K4 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27835356 0.83 AKR1C4 (0.41) KDM4ETMPRSS4P2RX1KDRMEN1
SCHEMBL11627576 0.83 TMPRSS4 (0.39) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL11626984 0.80 CYP3A4 (0.38) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL927354 0.76 TMPRSS4 (0.50) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL110827 0.76 RAB9A (0.49) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL22164127 0.73 CES2 (0.47) RAB9ACYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL816784 0.72 CES2 (0.35) RAB9ACYP1A2CYP2D6CYP2C19KDR
SCHEMBL2189933 0.72 LMNA (0.46) P2RX7SMN1; SMN2
SCHEMBL28208232 0.72 CES2 (0.41) TMPRSS4P2RX1KDRMEN1IKBKB
SCHEMBL31591119 0.70 TMPRSS4 (0.41) RAB9ACYP1A2CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109928967-A A kind of cyclisation berberinc derivate and its preparation method and application 中国医学科学院医药生物技术研究所 2019-06-25 CN disclosed
CN-104496930-B A kind of optical purity Aprepitant bulk drug intermediate preparation method JIANGSU ALPHA PHARMACEUTICAL CO., LTD. (CN) 2016-05-25 CN disclosed